About Gland Pharma
Gland Pharma is a company based in Hyderabad (India) founded in 1978 by Ravi Penmetsa and Pvn Raju was acquired by Fosun in July 2016.. Gland Pharma has raised $208.59 million across 1 funding round from investors including KKR, Fosun and Gland Celsus Bio Chemicals. The company has 4,350 employees as of March 31, 2024. Gland Pharma has completed 1 acquisition, including Cenexi. Gland Pharma operates in a competitive market with competitors including Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences, ApiJect and August Bioservices, among others.
- Headquarter Hyderabad, India
- Employees 4350 as on 31 Mar, 2024
- Founders Ravi Penmetsa, Pvn Raju
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gland Pharma Ltd.
-
Annual Revenue
$653.04 M (USD)-0.91as on Mar 31, 2024
-
Net Profit
$81.66 M (USD)-9.57as on Mar 31, 2024
-
EBITDA
$149.42 M (USD)-4.24as on Mar 31, 2024
-
Total Equity Funding
$208.59 M (USD)
in 1 rounds
-
Latest Funding Round
$208.59 M (USD), Unspecified
Nov 28, 2013
-
Investors
KKR
& 2 more
-
Employee Count
4350
as on Mar 31, 2024
- Investments & Acquisitions
-
Acquired by
Fosun
(Jul 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gland Pharma
Gland Pharma is a publicly listed company on the NSE with ticker symbol GLAND in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Gland Pharma
Gland Pharma has successfully raised a total of $208.59M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $208.59 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Unspecified — $208.6M
-
First Round
First Round
(28 Nov 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2013 | Amount | Unspecified - Gland Pharma | Valuation | KKR |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gland Pharma
Gland Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Fosun and Gland Celsus Bio Chemicals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Provider of legal, accounting, book keeping, and tax consulting services
|
Founded Year | Domain | Location | |
|
Diversified investment, asset management, and insurance services are offered globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gland Pharma
Gland Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cenexi. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pre-formulation and formulation services are provided in pharmaceuticals.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Gland Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gland Pharma Comparisons
Competitors of Gland Pharma
Gland Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences, ApiJect and August Bioservices, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| domain | founded_year | HQ Location |
Developer and manufacturer of pharmaceutical products
|
|
| domain | founded_year | HQ Location |
Nasal spray drug products are developed, manufactured, and commercialized.
|
|
| domain | founded_year | HQ Location |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| domain | founded_year | HQ Location |
Diversified research services for clinical solutions are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gland Pharma
Frequently Asked Questions about Gland Pharma
When was Gland Pharma founded?
Gland Pharma was founded in 1978 and raised its 1st funding round 35 years after it was founded.
Where is Gland Pharma located?
Gland Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Gland Pharma?
Srinivas Sadu is the current CEO of Gland Pharma.
Is Gland Pharma a funded company?
Gland Pharma is a funded company, having raised a total of $208.59M across 1 funding round to date. The company's 1st funding round was a Unspecified of $208.59M, raised on Nov 28, 2013.
How many employees does Gland Pharma have?
As of Mar 31, 2024, the latest employee count at Gland Pharma is 4,350.
What is the annual revenue of Gland Pharma?
Annual revenue of Gland Pharma is $653.04M as on Mar 31, 2024.
What does Gland Pharma do?
The company was founded in 1978 in Hyderabad, India, and operates in the pharmaceutical sector as a manufacturer of generic injectable drugs. A portfolio of products has been established in sterile injectables, oncology, and ophthalmics, with emphasis on complex injectables and various delivery systems. Diverse injectable needs are addressed through a stable supply chain, serving global markets from its base in India.
Who are the top competitors of Gland Pharma?
Gland Pharma's top competitors include Exela Pharma, Luoxin Pharmaceutical Group and Summit Biosciences.
Is Gland Pharma publicly traded?
Yes, Gland Pharma is publicly traded on NSE under the ticker symbol GLAND.
How many acquisitions has Gland Pharma made?
Gland Pharma has made 1 acquisition, including Cenexi.
Who are Gland Pharma's investors?
Gland Pharma has 3 investors. Key investors include KKR, Fosun, and Gland Celsus Bio Chemicals.
What is Gland Pharma's ticker symbol?
The ticker symbol of Gland Pharma is GLAND on NSE.
What is Gland Pharma's valuation?
The valuation of Gland Pharma is $445.93M as of Nov 2013.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.